Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
You L, Wang T, Li W, Zhang J, Zheng C, Zheng Y, Li S, Shang Z, Lin J, Wang F, Qian Y, Zhou Z, Kong X, Gao Y, Sun X.
You L, et al. Among authors: shang z.
J Ethnopharmacol. 2024 Apr 7;329:118165. doi: 10.1016/j.jep.2024.118165. Online ahead of print.
J Ethnopharmacol. 2024.
PMID: 38588984
Free article.